As of April 29, 2025, Tharimmune (THAR) has a market cap of $3.121 million USD. According to our data, Tharimmune is ranked No.9109 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $3.12 M |
-20.50%
|
Dec 31, 2024 | $3.93 M |
-73.41%
|
Dec 29, 2023 | $14.76 M |
-94.78%
|
Dec 30, 2022 | $0.28 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Regeneron Pharmaceuticals
REGN
|
$62.20 B |
1.034 B
|
![]() USA
|
![]() Amgen
AMGN
|
$152.20 B |
0.126 B
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$132.39 B |
-0.001 M
|
![]() USA
|
![]() Biogen
BIIB
|
$17.59 B |
0.000 M
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$127.64 B |
0.004 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.76 B |
0.000 M
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$12.13 B |
0.000 M
|
![]() USA
|
![]() Incyte
INCY
|
$11.69 B |
0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$33.29 B |
-0.001 M
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$5.98 B |
0.000 M
|
![]() USA
|
![]() Ionis Pharmaceuticals
IONS
|
$4.74 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$40.34 M |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.23 B |
-0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.13 B |
0.000 M
|
![]() USA
|
Market Cap | = | THAR Stock Price | * | THAR Shares Outstanding |
= | $1.48 | * | 2.11 M | |
= | $3.12 M |